Framlington is offering a 1% discount on its initial charge for investments of £7000 before the end ...
Framlington is offering a 1% discount on its initial charge for investments of £7000 before the end of this year's Isa season, into its new fund the Framlington Biotech Isa and the Framlington Health Isa..
The Biotech Fund was launched in November 2001, which takes a minimum investment of £1000 and regular premium payments of £50, has raised £18m so far.
Its portfolio comprises of around 70 global stocks, with 80% of investment in the US.
Annual management charge of the Biotech Fund is 1.75% with a standard initial charge of 5.5%.
The Health ISA has minimum investment of £500, with annual management charge of 1.5% and initial charge of 5.5%.
Intermediaries will be entitled to 3% up-front commission and 0.5% trail commission.
For more information contact 0845 766 0184 or click thru the right-hand link.
Partner Insight: Cathi Harrison, director of para-sols and Apricity and Clare Farrell managing director at Northfield Wealth met in London recently to discuss how to stay on top of regulatory risk.
CEO labels whistle-blower as 'brave'
Adds up to £130m FUM
Our weekly heads-up for advisers
Think tank report